Form 4: Oncocyte Corp: Patrick W. Smith Increases Indirect Holdings Through Trust

Patrick W. Smith, a director of Oncocyte Corp, reports increased indirect ownership of common stock through the Smith Irrevocable Trust.

Summary

• On January 13, 2025, Patrick W. Smith, a director of Oncocyte Corp, indirectly acquired 5,669 shares of common stock at $2.08 per share.
• On January 14, 2025, Smith indirectly acquired 100 shares of common stock at $2.08 per share.
• On the same day, Smith indirectly acquired another 10,286 shares of common stock at $2.15 per share.
• These transactions increased Smith's indirect holdings to 1,789,958 shares of Oncocyte Corp common stock.
• The shares are held by the Smith Irrevocable Trust, for which Smith serves as trustee.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It reflects insider buying, which can be seen as positive, but it's a routine transaction through a trust and doesn't necessarily indicate strong conviction.

Positives

• Director Smith's increased investment could be interpreted as a positive signal regarding his confidence in Oncocyte Corp's future prospects.

Industry Context

Form 4 filings are a routine part of regulatory compliance for corporate insiders and provide transparency into their trading activities. These filings are closely watched by investors seeking insights into management's perspective on the company's value and future prospects.

Stakeholder Impact

• The increased holdings by a director may positively influence shareholder sentiment.

Key Dates